AMALGAMATED BANK - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16
-11.1%
15,5180.0%0.00%
Q2 2023$18
-18.2%
15,518
+7.8%
0.00%
Q1 2023$22
-46.3%
14,401
-13.0%
0.00%
Q4 2022$41
-99.9%
16,5610.0%0.00%
-100.0%
Q3 2022$70,000
+55.6%
16,561
+1.6%
0.00%
Q2 2022$45,000
-47.7%
16,295
+8.3%
0.00%
-100.0%
Q1 2022$86,000
-71.1%
15,043
-53.9%
0.00%0.0%
Q4 2021$298,000
+69.3%
32,622
+97.9%
0.00%0.0%
Q3 2021$176,000
-35.1%
16,488
-5.5%
0.00%
-50.0%
Q2 2021$271,000
+34.2%
17,447
+40.0%
0.00%
-75.0%
Q1 2021$202,000
-30.3%
12,463
-9.0%
0.01%
-27.3%
Q4 2020$290,000
+43.6%
13,703
+0.6%
0.01%
+22.2%
Q3 2020$202,000
-1.9%
13,626
-2.9%
0.01%
-10.0%
Q2 2020$206,000
+16.4%
14,029
-7.2%
0.01%
+150.0%
Q1 2020$177,000
-51.9%
15,113
-3.4%
0.00%
-42.9%
Q4 2019$368,000
+52.7%
15,648
+20.2%
0.01%
+40.0%
Q3 2019$241,000
-2.0%
13,017
-1.5%
0.01%
-16.7%
Q2 2019$246,000
-4.7%
13,214
+25.3%
0.01%0.0%
Q1 2019$258,000
-1.9%
10,547
+4.1%
0.01%
-14.3%
Q4 2018$263,000
-30.6%
10,128
+3.9%
0.01%
-22.2%
Q2 2018$379,0009,7450.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders